In the present study, we detected a greater proportion of positive serum anti-PLA2R antibodies in IMN patients with FSGS, implying that more M-type phospholipase A2 receptors in the glomerulus were saturated and bound to anti-PLA2R, which caused more severe podocyte injury. The gene discussed is PLA2R1; the disease is focal segmental glomerulosclerosis.